Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. discloses new DNA polymerase inhibitors

July 14, 2022

UCB SA patents DRD1 PAMs

July 14, 2022

Novel genetic polymorphism associated with macroangiopathy risk

July 14, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Novel genetic loci found for venous thromboembolism

July 13, 2022

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

July 13, 2022

Targeting IL-33 release may be an approach for treating HCC

July 13, 2022

Co-targeting MAPK and YAP-TEAD signaling as therapeutic strategy in melanoma

July 13, 2022

Royal College of Surgeons in Ireland discloses HDAC6 inhibitors

July 13, 2022

Chinese researchers synthesize new GTPase KRAS inhibitors

July 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...